Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma by Hanley N. Abramson

Get full text

B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple Myeloma by Hanley N. Abramson

Get full text

Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future by Hanley N. Abramson

Get full text

Pollution control in chemical and Allied industries / by 528274 Hanley, N., Bhatia, S. C.

Local people's preferences for biodiversity offsets to achieve ‘no net loss’ for economic developments by Griffiths, VF, Sheremet, O, Hanley, N, Baker, J, Bull, JW, Milner-Gulland, EJ

How do international student returnees contribute to the development of their home countries? A systematic mapping and thematic synthesis by Wang, Z, Hanley, N, Kwak, J, Vari-Lavoisier, I, Al Hussein, M, Sanchez Tyson, L, Akkad, A, Chankseliani, M

Insights into the molecular mechanism for type 2 diabetes susceptibility at the KCNQ1 locus from temporal changes in imprinting status in human islets. by Travers, M, Mackay, D, Dekker Nitert, M, Morris, A, Lindgren, C, Berry, A, Johnson, P, Hanley, N, Groop, L, McCarthy, M, Gloyn, A

Altered phenotype of β-cells and other pancreatic cell lineages in patients with diffuse congenital hyperinsulinism in infancy caused by mutations in the ATP-sensitive K-channel by Salisbury, R, Han, B, Jennings, R, Berry, A, Stevens, A, Mohamed, Z, Sugden, S, De Krijger, R, Cross, S, Johnson, P, Newbould, M, Cosgrove, K, Hanley, K, Banerjee, I, Dunne, M, Hanley, N

Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. by Morán, I, Akerman, I, van de Bunt, M, Xie, R, Benazra, M, Nammo, T, Arnes, L, Nakić, N, García-Hurtado, J, Rodríguez-Seguí, S, Pasquali, L, Sauty-Colace, C, Beucher, A, Scharfmann, R, van Arensbergen, J, Johnson, P, Berry, A, Lee, C, Harkins, T, Gmyr, V, Pattou, F, Kerr-Conte, J, Piemonti, L, Berney, T, Hanley, N